Overview

Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients

Status:
Withdrawn
Trial end date:
2014-01-17
Target enrollment:
Participant gender:
Summary
Develop and quantify methods for evaluating bladder dysfunction in diabetes and stroke
Phase:
Early Phase 1
Details
Lead Sponsor:
Saint Thomas Health
Saint Thomas Health Services
Collaborator:
Pfizer
Treatments:
Cholinergic Antagonists
Fesoterodine
Tolterodine Tartrate